About
Description
eNUVIO creates cutting-edge microfabricated devices for use by scientists in the academic and pharmaceutical industry, particularly in the field of neuroscience. Specifically, eNUVIO aims to accelerate research in neurodegeneration. Applying new approaches developed in-house, they create state-of-the-art microfabricated consumables designed for use in cell culture. Their products fulfill the need for novel and suitable tools and assays that can take advantage of emerging biological technologies such as stem cells and 3D culture systems. The technologies are also specially designed to be easily adapted to high-throughput screening tests in the pharmaceutical industry. eNUVIO also offers fully customized contract research services. Their team of scientists specializes in human-relevant in vitro disease models featuring: AXOTOMY // NEURONAL EXCITOTOXICITY // NEURONAL PROPAGATION AXON GUIDANCE AND CHEMOTAXIS 3D MUSCLE CULTURES // NEUROMUSCULAR JUNCTION MODELS (2D-3D) NEURAL SPHEROIDS With a strong focus on neurodegenerative and neuromuscular disease models for preclinical services, eNUVIO is here to help you take your research to the next level.
Services
Life Cycle Assessment (LCA)
Analyze the lifecycles of products and services with regard to their environmental impacts.
Viral Vector Production
Produce viral vectors for gene therapy and vaccine development.
Data Visualization
Visualize data collected from clinical trials and/or clinical research.
Emerging Market Opportunities
Analyze risks and opportunities in new markets for patient access to new treatments.
Adverse Event Reporting
Monitor and report adverse events related to drug products in clinical trials.
Organization members
Amanda Lee
Communications Director
William Kim
Data Analyst
Laura Martinez
Clinical Trials Coordinator
Michael Brown
Executive Director
Robert Garcia
Fundraising Director
Emily Davis
Research Scientist